CFI-402257 in Combination With Paclitaxel in Patients With Advanced/Metastatic HER2-Negative Breast Cancer
CFI-402257 in Combination With Paclitaxel in Patients With Advanced/Metastatic HER2-Negative Breast Cancer
Active, not recruiting · NCT03568422 · Registry updated 2026-03-27Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| CFI-402257 in Combination With Paclitaxel in Patients With Advanced/Metastatic HER2-Negative Breast Cancer | Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder | Active, not recruiting | Phase 1 / Phase 2 | 2026-03-27 | NCT03568422 |
4 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Canadian Breast Cancer Foundation | 1 |
| Canadian Cancer Trials Group | 73 |
| Ontario Institute for Cancer Research | 4 |
| Stand Up To Cancer | 20 |
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| BCCA - Vancouver Cancer Centre | Vancouver | Canada | 11 |
| Kingston Health Sciences Centre | Kingston | Canada | 91 |
| Ottawa Hospital Research Institute | Ottawa | Canada | 46 |
| University Health Network | Toronto | Canada | 52 |